Contractualist reasoning, HIV cure clinical trials, and the moral (ir)relevance of the risk/benefit ratio

Institutional review boards (IRB) normally require of a morally defensible clinical trial that any trial participant will benefit from the inquiry, or at least not be exposed to a significant risk of having their prospects worsened by participating. Stage 1 HIV cure trials tend not to meet this requ...

Full description

Saved in:  
Bibliographic Details
Main Author: Kumar, Rahul (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: BMJ Publ. 2017
In: Journal of medical ethics
Year: 2017, Volume: 43, Issue: 2, Pages: 124-127
Online Access: Volltext (JSTOR)
Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000caa a22000002 4500
001 181615511X
003 DE-627
005 20230426115853.0
007 cr uuu---uuuuu
008 220908s2017 xx |||||o 00| ||eng c
024 7 |a 10.1136/medethics-2015-103127  |2 doi 
035 |a (DE-627)181615511X 
035 |a (DE-599)KXP181615511X 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Kumar, Rahul  |e VerfasserIn  |4 aut 
245 1 0 |a Contractualist reasoning, HIV cure clinical trials, and the moral (ir)relevance of the risk/benefit ratio 
264 1 |c 2017 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Institutional review boards (IRB) normally require of a morally defensible clinical trial that any trial participant will benefit from the inquiry, or at least not be exposed to a significant risk of having their prospects worsened by participating. Stage 1 HIV cure trials tend not to meet this requirement. Does that show them to be morally indefensible? Utilitarian thinking about this question supports a negative answer. But one might reasonably expect a Kantian moral theory to support the conclusion that exposing trial participants to a significant risk of their prospects being worsened by their participation to be morally indefensible, on grounds that this would be a clear case of using a person as a mere means. In this paper, I argue, drawing on Kantian contractualist thinking, that requiring the risk/benefit ratio for participants be positive if a trial is to be morally defensible does not in fact gain any support from Kantian thinking about morality. 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 43(2017), 2, Seite 124-127  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnns 
773 1 8 |g volume:43  |g year:2017  |g number:2  |g pages:124-127 
856 |3 Volltext  |u http://www.jstor.org/stable/44606078  |x JSTOR 
856 |u https://jme.bmj.com/content/medethics/43/2/124.full.pdf  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [open (via page says license)] 
856 4 0 |u https://doi.org/10.1136/medethics-2015-103127  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://jme.bmj.com/content/43/2/124.abstract  |x Verlag  |z kostenfrei  |3 Volltext 
935 |a mteo 
936 u w |d 43  |j 2017  |e 2  |h 124-127 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4185609051 
LOK |0 003 DE-627 
LOK |0 004 181615511X 
LOK |0 005 20220908053705 
LOK |0 008 220908||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-08-03#CEE6DCA9EA6729DDB0FA4A9BD142F558427AF5D1 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 866   |x JSTOR#http://www.jstor.org/stable/44606078 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw